Results 21 to 30 of about 8,097 (170)

Retinal findings in membranoproliferative glomerulonephritis

open access: yesAmerican Journal of Ophthalmology Case Reports, 2017
Purpose: To assess the evolution of retinal findings in patients with membranoproliferative glomerulonephritis (MPGN) by funduscopy, intravenous fluorescein angiography and optical coherence tomography. Observations: Three women and one man were followed
Ahmad M. Mansour   +6 more
doaj   +1 more source

Crescentic membranoproliferative glomerulonephritis in HIV infection; a mini-review with case study [PDF]

open access: yesJournal of Nephropathology, 2022
HIV-related renal diseases have become more evident and easier to treat due to the prolonged survival of patients with HIV infection on antiretroviral therapy (ART). There are multiple factors involved in the pathogenesis of this entity.
Priti Meena   +6 more
doaj   +1 more source

Pathology of C3 Glomerulopathy [PDF]

open access: yesChildhood Kidney Diseases, 2019
C3 glomerulopathy is a renal disorder involving dysregulation of alternative pathway complement activation. In most instances, a membranoproliferative pattern of glomerular injury with a prevalence of C3 deposition is observed by immunofluorescence ...
Su-Jin Shin, Yoonje Seong, Beom Jin Lim
doaj   +1 more source

Cryoglobulinemic Glomerulonephritis: A Case Report

open access: yesSiriraj Medical Journal, 2017
Cryoglobulinemic glomerulonephritis (CG) is rare in children. We report a 13-year-old Thai boy who presented with acute nephrotic nephritis syndrome, arthralgia, and purpura. Renal pathology revealed membranoproliferative glomerulonephritis and CG.
Nuntawan Piyaphanee
doaj   +3 more sources

Anaerococcus urinomassiliensis sp. nov., isolated from a urine sample of a 17-year-old boy affected by autoimmune hepatitis and membranoproliferative glomerulonephritis

open access: yesNew Microbes and New Infections, 2016
We report the main characteristics of ‘Anaerococcus urinomassiliensis’ strain FC4T (CSURP2143) that was isolated from a urine sample of a 17-year-old boy affected by autoimmune hepatitis and membranoproliferative glomerulonephritis.
A. Morand   +6 more
doaj   +1 more source

Secondary membranoproliferative glomerulonephritis

open access: yesKidney International, 1995
A 37-year-old man was transferred to Brigham and Women's Hospital for evaluation of progressive renal failure. His medical history was notable for intravenous drug use and heavy ethanol consumption but he denied their use for the last 7 years. He had had at least one bout of alcoholic hepatitis, which was diagnosed about 8 years previously. The patient
openaire   +2 more sources

Randomised, phase 1 evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of iptacopan in healthy volunteers

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Overactivation of the alternative pathway (AP) underlies several diseases. Iptacopan is an oral, first‐in‐class, highly potent specific inhibitor of factor B, a key AP protease. Experimental Approach The analysis included data from two phase 1 randomised, volunteer‐blinded, placebo‐controlled studies: Study 1, a single ...
Irina Baltcheva   +5 more
wiley   +1 more source

Culture-negative subacute bacterial endocarditis masquerades as granulomatosis with polyangiitis (Wegener’s granulomatosis) involving both the kidney and lung

open access: yesBMC Nephrology, 2012
Background Subacute bacterial endocarditis (SBE) occasionally exhibits positive cytoplasmic anti-neutrophil cytoplasmic antibody (c-ANCA) of the anti-proteinase-3 (PR-3) type.
Peng Hui   +6 more
doaj   +1 more source

Review Article: Renal Safety Profiles of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, and Entecavir for the Treatment of Chronic Hepatitis B Infection—General and Special Populations

open access: yesAlimentary Pharmacology &Therapeutics, Volume 63, Issue 7, Page 945-954, April 2026.
Current first‐line NUCs show comparable renal safety profiles in CHB patients with no or mild kidney dysfunction, with growing evidence that favours TAF. Future prospective studies are needed to validate these findings, and more research should focus on CHB patients with diabetes mellitus who are at risk of CKD.
Lung‐Yi Mak   +2 more
wiley   +1 more source

Pediatric Non‐Lupus Full House Nephropathy: Case Report and Review of Literature

open access: yesClinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Lupus nephritis is a severe manifestation of systemic lupus erythematosus (SLE) typically characterized by glomerular “full‐house” immunofluorescence. However, non‐lupus nephropathies may occasionally exhibit similar patterns, creating diagnostic uncertainty.
Mohammad Firoz Anjum   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy